Leiders het eeuwige leven? Herinner je je dat gesprek tussen Poetin en Xi nog? Je moet ergens beginnen:
):
If so, dan weten we wel wat er precies aan de hand is, ondanks het 'feit' dat hij de meest gezonde mens is (In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly’s powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration’s “compassionate use” program—raising immediate questions if that sole patient is President Donald Trump, according to a report by Stat News.
The access request was first made in April, when the person was 79 years old (Trump turned 80 on June 14). It was made by a senior clinician at the National Institutes of Health named Ranganath Muniyappa, who requested it on behalf of a patient with refractory obesity, obstructive sleep apnea, and pulmonary hypertension, which is high blood pressure in the lungs. Sources told Stat this patient had spent a year on tirzepatide, a drug that targets the GLP-1 and GIP hormones. But the patient had achieved only moderate weight loss on the drug.
Humanist | Kernpower! | Determinist | Verken uw geest | Politiek dakloos
/f/image/O67MA11rmj75hd3l2j6k5Y4R.png?f=fotoalbum_large)
/f/image/dcSmyHsnTLQOwKA4z2eLPQbH.png?f=fotoalbum_large)